Orimo H, Nakamura T, Fukunaga M, Ohta H, Hosoi T, Uemura Y, et al. for the A-TOP(Adequate Treatment of Osteoporosis) research group. Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: Japanese Osteoporosis Intervention Trial(JOINT)-02. Cur Med Res Opin 2011;27:1273-84.
Carmel AS, Shieh A, Bang H, Bockman RS. The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≧33 ng/ml. Osteoporos Int 2012;23:2479-87.